Syndax Pharmaceuticals

This program provided access to an experimental drug called SNDX-5613 for patients with a specific type of relapsed or refractory acute leukemia who had run out of standard treatment options. It was designed for patients who could not join other clinical trials and had no approve…

This study is testing a drug called axatilimab for people with chronic graft-versus-host disease (cGVHD) that has come back or hasn't improved after trying at least two other treatments. The goal is to see if the drug can reduce the disease's severity and symptoms, and to find th…